{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:08:01Z","timestamp":1779106081581,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-023808"],"award-info":[{"award-number":["INV-023808"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-003"],"award-info":[{"award-number":["2022-PUMCH-D-003"]}]},{"name":"Tencent Sustainable Social Value Inclusive Health Lab and through the ChongQing Tencent Sustainable Development Foundation","award":["SD20240904145730"],"award-info":[{"award-number":["SD20240904145730"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02504-w","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:46:29Z","timestamp":1773999989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in over- and under-screening for cervical cancer after EMR implementation in rural China"],"prefix":"10.1038","volume":"9","author":[{"given":"Yitong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huike","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxiu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2504_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"key":"2504_CR2","doi-asserted-by":"publisher","first-page":"e244090","DOI":"10.1001\/jamanetworkopen.2024.4090","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Cervical cancer screening via visual inspection with acetic acid and Lugol's iodine for triage of HPV-positive women. JAMA Netw. Open 7, e244090\u2013e244090 (2024).","journal-title":"JAMA Netw. Open"},{"key":"2504_CR3","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/cncr.33795","volume":"127","author":"S Lin","year":"2021","unstructured":"Lin, S. et al. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer 127, 4030\u20134039 (2021).","journal-title":"Cancer"},{"key":"2504_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins, R. B. et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J. Low. Genit. Trac. Dis. 24, 102\u2013131 (2020).","journal-title":"J. Low. Genit. Trac. Dis."},{"key":"2504_CR5","doi-asserted-by":"publisher","first-page":"q2840","DOI":"10.1136\/bmj.q2840","volume":"387","author":"JH Tanne","year":"2024","unstructured":"Tanne, J. H. Cervical cancer: US taskforce recommends HPV tests for screening, in updated guidelines. BMJ 387, q2840 (2024).","journal-title":"BMJ"},{"key":"2504_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gocm.2023.10.005","volume":"3","author":"M Li","year":"2023","unstructured":"Li, M. et al. Guidelines for cervical cancer screening in China. Gynecol. Obstet. Clin. Med. 3, 189\u2013194 (2023).","journal-title":"Gynecol. Obstet. Clin. Med."},{"key":"2504_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2022.09.012","volume":"167","author":"YW Lee","year":"2022","unstructured":"Lee, Y. W., Morgan, J. R., Fiascone, S. & Perkins, R. B. Underscreening, overscreening, and guideline-adherent cervical cancer screening in a national cohort. Gynecol. Oncol. 167, 181\u2013188 (2022).","journal-title":"Gynecol. Oncol."},{"key":"2504_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamainternmed.2014.1541","volume":"174","author":"AL Schwartz","year":"2014","unstructured":"Schwartz, A. L., Landon, B. E., Elshaug, A. G., Chernew, M. E. & McWilliams, J. M. Measuring low-value care in Medicare. JAMA Intern. Med. 174, 1067\u20131076 (2014).","journal-title":"JAMA Intern. Med."},{"key":"2504_CR9","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.2021.3308","volume":"325","author":"AH Oakes","year":"2021","unstructured":"Oakes, A. H. & Radomski, T. R. Reducing low-value care and improving health care value. JAMA 325, 1715\u20131716 (2021).","journal-title":"JAMA"},{"key":"2504_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ypmed.2018.08.027","volume":"116","author":"JM Alber","year":"2018","unstructured":"Alber, J. M. et al. Reducing overuse of cervical cancer screening: a systematic review. Prevent. Med. 116, 51\u201359 (2018).","journal-title":"Prevent. Med."},{"key":"2504_CR11","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1056\/NEJMp1404503","volume":"371","author":"CH Colla","year":"2014","unstructured":"Colla, C. H. Swimming against the current\u2014what might work to reduce low-value care?. N. Engl. J. Med. 371, 1280 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2504_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/AOG.0000000000001804","volume":"129","author":"N Parekh","year":"2017","unstructured":"Parekh, N., Donohue, J. M., Men, A., Corbelli, J. & Jarlenski, M. Cervical cancer screening guideline adherence before and after guideline changes in Pennsylvania Medicaid. Obstet. Gynecol. 129, 66\u201375 (2017).","journal-title":"Obstet. Gynecol."},{"key":"2504_CR13","first-page":"229","volume":"112","author":"A Buskwofie","year":"2020","unstructured":"Buskwofie, A., David-West, G. & Clare, C. A. A review of cervical cancer: incidence and disparities. J. Natl. Med. Assoc. 112, 229\u2013232 (2020).","journal-title":"J. Natl. Med. Assoc."},{"key":"2504_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ijc.30524","volume":"140","author":"D Habbema","year":"2017","unstructured":"Habbema, D. et al. Harms of cervical cancer screening in the United States and the Netherlands. Int. J. Cancer 140, 1215\u20131222 (2017).","journal-title":"Int. J. Cancer"},{"key":"2504_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106770","volume":"153","author":"RB Perkins","year":"2021","unstructured":"Perkins, R. B. et al. Clinical follow-up practices after cervical cancer screening by co-testing: a population-based study of adherence to US guideline recommendations. Prev. Med. 153, 106770 (2021).","journal-title":"Prev. Med."},{"key":"2504_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/LGT.0000000000000558","volume":"24","author":"CJ Min","year":"2020","unstructured":"Min, C. J., Massad, L. S., Dick, R., Powell, M. A. & Kuroki, L. M. Assessing physician adherence to guidelines for cervical cancer screening and management of abnormal screening results. J. Low. Genit. Trac. Dis. 24, 337\u2013342 (2020).","journal-title":"J. Low. Genit. Trac. Dis."},{"key":"2504_CR17","first-page":"482","volume":"19","author":"CM Almeida","year":"2013","unstructured":"Almeida, C. M. et al. Cervical cancer screening overuse and underuse: patient and physician factors. Am. J. Manag. Care 19, 482\u2013489 (2013).","journal-title":"Am. J. Manag. Care"},{"key":"2504_CR18","doi-asserted-by":"publisher","first-page":"ii6-ii10","DOI":"10.1136\/bmjqs-2012-001621","volume":"22","author":"PL Epner","year":"2013","unstructured":"Epner, P. L., Gans, J. E. & Graber, M. L. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Qual. Saf. 22, ii6-ii10 (2013).","journal-title":"BMJ Qual. Saf."},{"key":"2504_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-145-7-200610030-00006","volume":"145","author":"TK Gandhi","year":"2006","unstructured":"Gandhi, T. K. et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann. Intern. Med. 145, 488\u2013496 (2006).","journal-title":"Ann. Intern. Med."},{"key":"2504_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1200\/OP.2023.19.11_suppl.451","volume":"19","author":"M Shin","year":"2023","unstructured":"Shin, M., Axeen, S. & Tsui, J. Understanding over- and under-screening of cervical cancer among a national sample of commercially insured women: Implications for health equity. JCO Oncology Practice 19, 451\u2013451 (2023).","journal-title":"JCO Oncology Practice"},{"key":"2504_CR21","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, A. et al. Cervical cancer screening programme attendance and compliance predictors regarding Colombia\u2019s Amazon region. PLoS ONE 17, e0262069 (2022).","DOI":"10.1371\/journal.pone.0262069"},{"key":"2504_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2025.052","volume":"7","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Cervical Cancer Screening Rates Among Chinese Women\u2014China, 2023\u20132024. China CDC Wkly. 7, 321 (2025).","journal-title":"China CDC Wkly."},{"key":"2504_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ygyno.2023.06.007","volume":"175","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni, A. et al. Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals. Gynecol. Oncol. 175, 53\u201359 (2023).","journal-title":"Gynecol. Oncol."},{"key":"2504_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/bmjqs-2020-012576","volume":"31","author":"J M\u00fcskens","year":"2022","unstructured":"M\u00fcskens, J., Kool, R. B., van Dulmen, S. A. & Westert, G. P. Overuse of diagnostic testing in healthcare: a systematic review. BMJ Qual. Saf. 31, 54\u201363 (2022).","journal-title":"BMJ Qual. Saf."},{"key":"2504_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106770","volume":"153","author":"RB Perkins","year":"2021","unstructured":"Perkins, R. B. et al. Clinical follow-up practices after cervical cancer screening by co-testing: a population-based study of adherence to U.S. guideline recommendations. Prevent. Med. 153, 106770 (2021).","journal-title":"Prevent. Med."},{"key":"2504_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ygyno.2021.08.023","volume":"163","author":"J Qin","year":"2021","unstructured":"Qin, J. et al. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013\u20132019. Gynecol. Oncol. 163, 378\u2013384 (2021).","journal-title":"Gynecol. Oncol."},{"key":"2504_CR27","doi-asserted-by":"publisher","first-page":"e218373","DOI":"10.1001\/jamanetworkopen.2021.8373","volume":"4","author":"JD Wright","year":"2021","unstructured":"Wright, J. D. et al. Overuse of cervical cancer screening tests among women with average risk in the United States from 2013 to 2014. JAMA Netw. Open 4, e218373\u2013e218373 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2504_CR28","unstructured":"Numnum, T. M. & Huh, W. Cervical intra-epithelial neoplasia. Gynecol. Oncol. p.100. (2009)."},{"key":"2504_CR29","unstructured":"World Health, O. Weekly Epidemiological Record, 2009, Vol. 84, 40 [full issue]. 405\u2013420 (WHO, 2009)."},{"key":"2504_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ijc.32849","volume":"147","author":"G Sroczynski","year":"2020","unstructured":"Sroczynski, G. et al. Reducing overtreatment associated with overdiagnosis in cervical cancer screening-a model-based benefit-harm analysis for Austria. Int. J. Cancer 147, 1131\u20131142 (2020).","journal-title":"Int. J. Cancer"},{"key":"2504_CR31","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","volume":"15","author":"LJ Esserman","year":"2014","unstructured":"Esserman, L. J. et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 15, e234\u2013e242 (2014).","journal-title":"Lancet Oncol."},{"key":"2504_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","volume":"123","author":"AL Beavis","year":"2017","unstructured":"Beavis, A. L., Gravitt, P. E. & Rositch, A. F. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123, 1044\u20131050 (2017).","journal-title":"Cancer"},{"key":"2504_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/pon.2003","volume":"21","author":"M Drolet","year":"2012","unstructured":"Drolet, M. et al. The psychosocial impact of an abnormal cervical smear result. Psycho-Oncol. 21, 1071\u20131081 (2012).","journal-title":"Psycho-Oncol."},{"key":"2504_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/LGT.0000000000000008","volume":"18","author":"L Verrilli","year":"2014","unstructured":"Verrilli, L., Winer, R. L. & Mao, C. Adherence to cervical cancer screening guidelines by gynecologists in the Pacific Northwest. J. Low. Genit. Trac. Dis. 18, 228\u2013234 (2014).","journal-title":"J. Low. Genit. Trac. Dis."},{"key":"2504_CR35","first-page":"761","volume":"43","author":"C Hao","year":"2022","unstructured":"Hao, C., Changfa, X., Tingting, Y., Youlin, Q. & Fanghui, Z. Reasons for the rapid increase in cervical cancer burden among chinese women and corresponding countermeasures. Chin. J. Epidemiol. 43, 761\u2013765 (2022).","journal-title":"Chin. J. Epidemiol."},{"key":"2504_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.46234\/ccdcw2022.217","volume":"4","author":"Z Mei","year":"2022","unstructured":"Mei, Z. et al. Preplanned studies: cervical cancer screening coverage\u2014China, 2018\u20132019. China CDC Wkly. 4, 1077\u20131082 (2022).","journal-title":"China CDC Wkly."},{"key":"2504_CR37","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni, L. et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob. Health 10, e1115\u2013e1127 (2022).","journal-title":"Lancet Glob. Health"},{"key":"2504_CR38","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.3390\/ijerph19116874","volume":"19","author":"M Zhang","year":"2022","unstructured":"Zhang, M., Sit, J. W., Chan, D. N. S., Akingbade, O. & Chan, C. W. Educational interventions to promote cervical cancer screening among rural populations: a systematic review. Int. J. Environ. Res. Public Health 19, 6874 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"2504_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins, R. B., Wentzensen, N., Guido, R. S. & Schiffman, M. Cervical cancer screening: a review. JAMA 330, 547\u2013558 (2023).","journal-title":"JAMA"},{"key":"2504_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","volume":"8","author":"SL Bedell","year":"2020","unstructured":"Bedell, S. L., Goldstein, L. S., Goldstein, A. R. & Goldstein, A. T. Cervical cancer screening: past, present, and future. Sex. Med. Rev. 8, 28\u201337 (2020).","journal-title":"Sex. Med. Rev."},{"key":"2504_CR41","first-page":"5","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Research on insufficient follow-up of cervical cancer screening in Wuxiang County, Shanxi Province. China Mod. Dr. 12, 5\u20139 (2025).","journal-title":"China Mod. Dr."},{"key":"2504_CR42","doi-asserted-by":"publisher","first-page":"62. e61","DOI":"10.1016\/j.ajog.2014.06.057","volume":"212","author":"DG Teoh","year":"2015","unstructured":"Teoh, D. G. et al. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. Am. J. Obstet. Gynecol. 212, 62. e61\u201362. e69 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2504_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09498-0","volume":"22","author":"B Wei","year":"2022","unstructured":"Wei, B. et al. Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China. BMC Cancer 22, 388 (2022).","journal-title":"BMC Cancer"},{"key":"2504_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/14737159.2025.2486653","volume":"25","author":"M El-Zein","year":"2025","unstructured":"El-Zein, M. & Franco, E. L. Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination. Expert Rev. Mol. Diagn. 25, 157\u2013164 (2025).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2504_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jasc.2023.09.007","volume":"13","author":"AA Swanson","year":"2024","unstructured":"Swanson, A. A. & Pantanowitz, L. The evolution of cervical cancer screening. J. Am. Soc. Cytopathol. 13, 10\u201315 (2024).","journal-title":"J. Am. Soc. Cytopathol."},{"key":"2504_CR46","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez, A. T. et al. Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study. Lancet Reg. Health Am. 26, 100593 (2023).","DOI":"10.1016\/j.lana.2023.100593"},{"key":"2504_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"UPST Force","year":"2018","unstructured":"Force, U. P. S. T. Screening for cervical cancer us preventive services task force recommendation statement. JAMA. 320, 674\u2013686 (2018).","journal-title":"JAMA."},{"key":"2504_CR48","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1136\/amiajnl-2011-000536","volume":"19","author":"JS Mathias","year":"2012","unstructured":"Mathias, J. S., Gossett, D. & Baker, D. W. Use of electronic health record data to evaluate overuse of cervical cancer screening. J. Am. Med. Inform. Assoc. 19, e96\u2013e101 (2012).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"2504_CR49","doi-asserted-by":"publisher","first-page":"e2417094","DOI":"10.1001\/jamanetworkopen.2024.17094","volume":"7","author":"TF Borders","year":"2024","unstructured":"Borders, T. F. & Wiggins, A. T. Cervical cancer screening rates among rural and urban females, from 2019 to 2022. JAMA Netw. Open 7, e2417094\u2013e2417094 (2024).","journal-title":"JAMA Netw. Open"},{"key":"2504_CR50","doi-asserted-by":"publisher","first-page":"913361","DOI":"10.3389\/fmed.2022.913361","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Guo, J., Zhu, G., Zhang, B. & Feng, X. L. Changes in rate and socioeconomic inequality of cervical cancer screening in northeastern China from 2013 to 2018. Front. Med. 9, 913361 (2022).","journal-title":"Front. Med."},{"key":"2504_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/LGT.0000000000000435","volume":"22","author":"S Feldman","year":"2018","unstructured":"Feldman, S. et al. Cervical cancer incidence among elderly women in Massachusetts compared with younger women. J. Low. Genit. Trac. Dis. 22, 314\u2013317 (2018).","journal-title":"J. Low. Genit. Trac. Dis."},{"key":"2504_CR52","doi-asserted-by":"crossref","unstructured":"Xie, S., Pan, S., Zou, S., Zhu, H. & Zhu, X. Characteristics and treatments of patients aged 65 years or over with cervical cancer. Clin. Interv. Aging 15, 841\u2013851 (2020).","DOI":"10.2147\/CIA.S255305"},{"key":"2504_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2024.107982","volume":"183","author":"K Mooses","year":"2024","unstructured":"Mooses, K. et al. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: a cross-sectional study. Prevent. Med. 183, 107982 (2024).","journal-title":"Prevent. Med."},{"key":"2504_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pec.2013.10.007","volume":"93","author":"S Reis","year":"2013","unstructured":"Reis, S., Visser, A. & Frankel, R. Health information and communication technology in healthcare communication: The good, the bad, and the transformative. Patient Education and Counseling 93, 359\u2013362 (2013).","journal-title":"Patient Education and Counseling"},{"key":"2504_CR55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000452240","volume":"60","author":"LW Musselwhite","year":"2016","unstructured":"Musselwhite, L. W. et al. Racial\/ethnic disparities in cervical cancer screening and outcomes. Acta Cytol. 60, 518\u2013526 (2016).","journal-title":"Acta Cytol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02504-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02504-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02504-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:09:57Z","timestamp":1779102597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02504-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02504-w","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}